Skip to main content

Company for optimizing cancer therapy    +49-6221-8936-157     contact [at] therapyselect [dot] de   

Toggle menu
  • Home
  • Efficacy Tests for Cancer Drugs
    • General Information
      • Which Test for Whom?
      • Tumor Storage
      • Biomarker and Cancer
      • GTC Diagnostics
      • Chemosensitivity in Cancer
    • Using living tumor
      • CTR-Test® - Overview
      • CTR-Test® - Documents
      • Area of Application
      • Drug Selection
      • Process and Order
      • Reimbursement and Costs
      • Studies and Publications
      • FAQ about CTR-Test®
      • Quality Management
    • Using archived tumor
      • PCDx™ - Overview
      • PCDx™ - Documents
      • Area of Application
      • Process and Order
      • Reimbursement and Costs
      • Studies and Publications
      • FAQ about PCDx™
    • Using blood
      • Guardant360® - Overview
      • Area of Application
      • Process and Order
      • Reimbursement and Costs
      • Studies and Publications
      • FAQ about Guardant360®
  • Tumor Types
    • Bladder Cancer / Bladder Carcinoma
    • Brain Tumor / Glioma
    • Breast Cancer / Mamma Carcinoma
    • Cervical Cancer / Cervical Carcinoma
    • Colorectal Cancer / Colorectal Carcinoma
    • Lung Cancer – Non Small Cell Lung Carcinoma (NSCLC)
    • Lung Cancer – Small Cell Lung Carcinoma (SCLC)
    • Ovarian Cancer / Ovarian Carcinoma
    • Pancreatic Cancer / Pancreatic Carcinoma
    • Prostate Cancer / Prostate Carcinoma
    • Stomach Cancer / Gastric Cancer
  • Blog
  • News
  • About Us
    • Portrait
    • Management
    • Advisory Board
    • Cooperations
    • Awards
    • Job Openings
  • Contact
  • Support us

Search form

The BIOPRO Baden-Württemberg GmbH releases an article about TherapySelect

The BIOPRO releases an article about TherapySelect in the section "Biotechnologie & Pharma, Medizintehcnik, Diagnostick, Ernährung". The article is available online.

  • Link to the online article "TherapySelect – identifying susceptibility to cancer therapy"
  • Online article "TherapySelect: Für die beste Chemotherapie zur Krebsbehandlung" 2014 (archived) (only in German)pdficon_small.png
Posted on Monday, March 31, 2014
Previous
Next

logo_ts_2014.09.20_fk.png

TherapySelect Logo

Just call us:

Monday to Thursday from 9:00 - 16:00
and Friday from 9:00 - 15:00
Our phone number:
+49 6221-8936-157

Send us a message:

Link to contact form

We will get back to you as soon as possible.
Your TherapySelect Team

Some Awards

TherapySelect Dr. Frank Kischkel  |  Carl-Bosch-Str. 4  |  69115 Heidelberg  |  Germany
Tel: +49 – 6221 – 8936 – 157  |  Fax: +49 – 6221 – 8936 – 158  |  Email: contact [at] therapyselect [dot] de  |  Sitemap

  • Home
  • Log in
  • Legal Notice
  • Data Privacy
  • Certification